XML 29 R19.htm IDEA: XBRL DOCUMENT v3.24.3
Revenue recognition
 9 Months Ended
Sep. 28, 2024
Revenue from Contract with Customer [Abstract]  
Revenue recognition Revenue recognition
Our policies for recognizing sales have not changed from those described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023. The Company attributes net sales to external customers to the U.S. and to all foreign countries based on the legal entity from which the sale originated.
As previously discussed in Note 1. Organization, SonicOne revenue was reclassified from Restorative Therapies to Surgical Solutions on a prospective and retrospective basis as its capabilities to remove devitalized or necrotic tissue and fiber deposits more closely align with Surgical Solutions’ soft tissue management. SonicOne revenue reclassified for the three and nine months ended September 30, 2023 totaled $1,750 and $5,294, respectively, for the U.S. reporting segment and $65 and $214, respectively, for the International reporting segment. The Company had product sales to one customer totaling $12,933 and $44,342 primarily in the U.S. reporting segment during the three and nine months ended September 28, 2024, representing 9.3% and 10.6% of total net sales, respectively. There were no customers representing 10% or more of net sales during the three and nine months ended September 30, 2023. The following table presents the Company’s net sales disaggregated by major business within each segment as follows:
Three Months EndedNine Months Ended
September 28, 2024September 30, 2023September 28, 2024September 30, 2023
U.S.
Pain Treatments
$56,306 $48,416 $172,137 $145,028 
Restorative Therapies25,448 23,105 78,187 83,893 
Surgical Solutions41,155 34,706 121,275 102,131 
Total U.S. net sales122,909 106,227 371,599 331,052 
International
Pain Treatments
6,821 5,274 19,939 16,629 
Restorative Therapies4,489 5,223 13,844 15,462 
Surgical Solutions4,745 4,070 14,256 13,779 
Total International net sales16,055 14,567 48,039 45,870 
Total net sales$138,964 $120,794 $419,638 $376,922